Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vinphaco, officially known as Vinh Phuc Pharmaceutical Joint Stock Company, is a leading Vietnamese pharmaceutical manufacturer specializing in the production of injectable medicines. Established in 1959 and headquartered in Vinh Phuc province, the company operates advanced manufacturing facilities that adhere to WHO-GMP standards. Its extensive product portfolio comprises a wide range of generic drugs, including antibiotics, analgesics, and nutritional supplements, which are distributed across domestic and international markets. Vinphaco is widely recognized as a leader in the injectable drug segment in Vietnam, serving a significant portion of the country's hospital and clinical network. The company is publicly listed on the UPCoM stock exchange under the ticker symbol VDP.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vinphaco.